MX2009006744A - Panel de padecimiento cardiovascular autoinmune y metodos de utilizacion del mismo. - Google Patents

Panel de padecimiento cardiovascular autoinmune y metodos de utilizacion del mismo.

Info

Publication number
MX2009006744A
MX2009006744A MX2009006744A MX2009006744A MX2009006744A MX 2009006744 A MX2009006744 A MX 2009006744A MX 2009006744 A MX2009006744 A MX 2009006744A MX 2009006744 A MX2009006744 A MX 2009006744A MX 2009006744 A MX2009006744 A MX 2009006744A
Authority
MX
Mexico
Prior art keywords
cardiovascular
autoimmune disease
methods
disease
risk
Prior art date
Application number
MX2009006744A
Other languages
English (en)
Spanish (es)
Inventor
Robert C Doss
Phillip G Mattingly
Roy Jeffrey Brashear
Maciej B Adamczyk
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Publication of MX2009006744A publication Critical patent/MX2009006744A/es

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/32—Cardiovascular disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Rheumatology (AREA)
  • Rehabilitation Therapy (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
MX2009006744A 2006-12-22 2007-12-21 Panel de padecimiento cardiovascular autoinmune y metodos de utilizacion del mismo. MX2009006744A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US87660306P 2006-12-22 2006-12-22
PCT/US2007/088477 WO2008080030A2 (fr) 2006-12-22 2007-12-21 Panel de maladies auto-immunes cardiovasculaires et méthodes d'utilisation correspondantes

Publications (1)

Publication Number Publication Date
MX2009006744A true MX2009006744A (es) 2009-06-30

Family

ID=39563225

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2009006744A MX2009006744A (es) 2006-12-22 2007-12-21 Panel de padecimiento cardiovascular autoinmune y metodos de utilizacion del mismo.

Country Status (6)

Country Link
EP (1) EP2115466A4 (fr)
JP (1) JP2010515023A (fr)
BR (1) BRPI0720215A2 (fr)
CA (1) CA2669863A1 (fr)
MX (1) MX2009006744A (fr)
WO (1) WO2008080030A2 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2097750A2 (fr) 2006-10-26 2009-09-09 Abbott Laboratories Analyse immunologique d'analytes dans des echantillons contenant des anticorps anti-analytes endogenes
US20090286256A1 (en) * 2008-05-19 2009-11-19 Abbott Laboratories Isolated human autoantibodies to natriuretic peptides and methods and kits for detecting human autoantibodies to natriuretic peptides
EP2148203A1 (fr) * 2008-07-23 2010-01-27 BRAHMS Aktiengesellschaft Protéases de grains azurophiles en tant que marqueurs dans les maladies cardiologiques
US20110136141A1 (en) * 2009-12-03 2011-06-09 Abbott Laboratories Peptide reagents and method for inhibiting autoantibody antigen binding
EP2580593A4 (fr) * 2010-06-10 2014-04-16 Myra Lipes Diagnostic d'une auto-immunité myocardique dans une maladie cardiaque
US10775389B2 (en) 2015-09-09 2020-09-15 Medizinische Hochschule Hannover Method for detecting plasminogen activator inhibitor-1 in a sample
WO2021062298A1 (fr) * 2019-09-27 2021-04-01 Arterez, Inc. Traitement médicamenteux et panel de biomarqueurs ciblant des maladies dues à l'ontologie multifactorielle de l'interruption de la glycocalyx
CN112858687B (zh) * 2020-12-30 2023-09-15 宁波职业技术学院 一种血清淀粉样蛋白a检测试剂及其制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6309888B1 (en) * 1998-09-04 2001-10-30 Leuven Research & Development Vzw Detection and determination of the stages of coronary artery disease
GB0017641D0 (en) * 2000-07-18 2000-09-06 Medigene Oy Peptides and their use
SE0103754L (sv) * 2001-04-05 2002-10-06 Forskarpatent I Syd Ab Peptider från apolipoprotein B, användning därav immunisering, diagnosmetod eller terapeutisk behandling av ischemiska kardiovaskulära sjukdomar, samt farmaceutisk komposition och vaccin innehållande sådan peptid
US7632647B2 (en) * 2001-04-13 2009-12-15 Biosite Incorporated Use of B-type natriuretic peptide as a prognostic indicator in acute coronary syndromes
US20030100036A1 (en) * 2001-11-08 2003-05-29 Aristo Vojdani Saliva immunoassay for detection of antibodies for cardiovascular disease
US20050181451A1 (en) * 2004-02-12 2005-08-18 Bates Harold M. Detection of asymptomatic coronary artery disease using atherogenic proteins and acute phase reactants
ATE463254T1 (de) * 2004-04-15 2010-04-15 Athera Biotechnologies Ab Antikörper gegen phosphorylcholinkonjugate
WO2006103101A2 (fr) * 2005-03-31 2006-10-05 Julius-Maximilians-Universität Würzburg Moyens pour l'inhibition d'anticorps anti-recepteurs $g(b)1 adrenergiques
WO2007085411A1 (fr) * 2006-01-25 2007-08-02 Roche Diagnostics Gmbh Anticorps anti-troponine et risque cardiovasculaire
AU2007277146B2 (en) * 2006-07-26 2011-10-20 Inova Diagnostics, Inc. Compositions and methods for diagnosing patients with acute atherosclerotic syndromes

Also Published As

Publication number Publication date
WO2008080030A3 (fr) 2008-10-09
WO2008080030A2 (fr) 2008-07-03
EP2115466A4 (fr) 2010-07-28
BRPI0720215A2 (pt) 2013-12-24
JP2010515023A (ja) 2010-05-06
EP2115466A2 (fr) 2009-11-11
CA2669863A1 (fr) 2008-07-03

Similar Documents

Publication Publication Date Title
MX2009004463A (es) Ensayo para anticuerpos de troponina cardiaca.
MX2009006744A (es) Panel de padecimiento cardiovascular autoinmune y metodos de utilizacion del mismo.
Uhm et al. The association between shift work and chronic kidney disease in manual labor workers using data from the Korea National Health and Nutrition Examination Survey (KNHANES 2011–2014)
Lurz et al. Frailty in children with liver disease: a prospective multicenter study
Fischer et al. Unique characteristics of systemic sclerosis sine scleroderma-associated interstitial lung disease
WO2012056236A3 (fr) Procédés d'analyse et puces utilisables à cet effet
EP2319941A3 (fr) Procédé et appareil pour corréler des niveaux de produits biomarqueurs avec une maladie
Rodríguez-Violante et al. Clinical determinants of health-related quality of life in Mexican patients with Parkinson’s disease
EP3185013A3 (fr) Biomarqueurs pour déterminer un xénotype tolérant à l'allogreffe
WO2006024466A3 (fr) Dispositif d'essai pour diagnostic in vitro d'essais multi-analytes et son utilisation
SG171691A1 (en) Biomarkers for diagnosing multiple sclerosis, and methods thereof
MY207814A (en) Combination of biomarkers for diagnosing of diabetic retinopathy and use thereof
ATE557101T1 (de) Verfahren und zusammensetzungen zur bestimmung eines transplantationstoleranten phänotyps in einem individuum
EP2415877A3 (fr) Moyens et procédés pour diagnostiquer un cancer pancréatique
EP2044212A4 (fr) Procedes d'identification de patients courant un risque accru d'episode cardiovasculaire indesirable
Motta et al. Assessing secondary trauma.
MX2021009281A (es) Metodos de deteccion de legionella.
ATE503847T1 (de) Verfahren und kits zur diagnose von multipler sklerose bei wahrscheinlichen multiple-sklerose- patienten
NZ540750A (en) Sets of oligonucleotide probes for diagnosis
Sogbe et al. Psychomotor speed from minimal hepatic encephalopathy testing is associated with physical frailty in patients with advanced chronic liver disease
EP1767652A4 (fr) Gene marqueur et utilisation correspondante
Gençöz et al. Hopelessness and suicidality in Turkish and American respondents
ATE437182T1 (de) Diagnose von allergischen erkrankungen, atopischen erkrankungen und/oder autoimmunerkrankungen durch nachweis von autoantikörpern gegen cd28 in humanem serum
장은영 Social comparison and adjustment in two cultures
Campbell et al. Concurrent validity of the College Adjustment Scales using comparison with the MMPI College Maladjustment Scale

Legal Events

Date Code Title Description
FG Grant or registration